Author:
Ahn Su Jeong,Baek Yun Hee,Lloren Khristine Kaith S.,Choi Won-Suk,Jeong Ju Hwan,Antigua Khristine Joy C.,Kwon Hyeok-il,Park Su-Jin,Kim Eun-Ha,Kim Young-il,Si Young-Jae,Hong Seung Bok,Shin Kyeong Seob,Chun Sungkun,Choi Young Ki,Song Min-Suk
Abstract
Abstract
Background
In addition to seasonal influenza viruses recently circulating in humans, avian influenza viruses (AIVs) of H5N1, H5N6 and H7N9 subtypes have also emerged and demonstrated human infection abilities with high mortality rates. Although influenza viral infections are usually diagnosed using viral isolation and serological/molecular analyses, the cost, accessibility, and availability of these methods may limit their utility in various settings. The objective of this study was to develop and optimized a multiplex detection system for most influenza viruses currently infecting humans.
Methods
We developed and optimized a multiplex detection system for most influenza viruses currently infecting humans including two type B (both Victoria lineages and Yamagata lineages), H1N1, H3N2, H5N1, H5N6, and H7N9 using Reverse Transcriptional Loop-mediated Isothermal Amplification (RT-LAMP) technology coupled with a one-pot colorimetric visualization system to facilitate direct determination of results without additional steps. We also evaluated this multiplex RT-LAMP for clinical use using a total of 135 clinical and spiked samples (91 influenza viruses and 44 other human infectious viruses).
Results
We achieved rapid detection of seasonal influenza viruses (H1N1, H3N2, and Type B) and avian influenza viruses (H5N1, H5N6, H5N8 and H7N9) within an hour. The assay could detect influenza viruses with high sensitivity (i.e., from 100 to 0.1 viral genome copies), comparable to conventional RT-PCR-based approaches which would typically take several hours and require expensive equipment. This assay was capable of specifically detecting each influenza virus (Type B, H1N1, H3N2, H5N1, H5N6, H5N8 and H7N9) without cross-reactivity with other subtypes of AIVs or other human infectious viruses. Furthermore, 91 clinical and spiked samples confirmed by qRT-PCR were also detected by this multiplex RT-LAMP with 98.9% agreement. It was more sensitive than one-step RT-PCR approach (92.3%).
Conclusions
Results of this study suggest that our multiplex RT-LAMP assay may provide a rapid, sensitive, cost-effective, and reliable diagnostic method for identifying recent influenza viruses infecting humans, especially in locations without access to large platforms or sophisticated equipment.
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Influenza (Seasonal) Fact sheet. http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal).
2. Influenza (Avian and other zoonotic) Fact sheets. http://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic).
3. EMPRES Global Animal Disease Information System. http://empres-i.fao.org/eipws3g/.
4. H7N9 situation update. http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html. Accessed 30 Apr 2019.
5. Dobrovolny HM, Gieschke R, Davies BE, Jumbe NL, Beauchemin CA. Neuraminidase inhibitors for treatment of human and avian strain influenza: a comparative modeling study. J Theor Biol. 2011;269(1):234–44.